Alnylam Pharmaceuticals
ALNY
#1112
Rank
$21.18 B
Marketcap
$158.18
Share price
1.00%
Change (1 day)
-64.19%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company